上游开放的读取框架编码的MP31破坏了线粒体质量控制过程,并抑制了质母细胞瘤中的瘤发生
Nunu Huang1,2, Zhipeng Chen1,2, Xuesong Yang1,2
1Department of Neurosurgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Neuro-oncology
|June 6, 2023
概括
微片MP31通过抑制线粒体质量控制 (MQC) 来破坏质母细胞瘤 (GBM) 线粒体平衡. 这增强了化疗的有效性,并显示了不损害正常细胞的GBM治疗的前景.
科学领域:
- 线粒体生物学 线粒体生物学
- 癌症研究 癌症研究
- 分子疗法分子疗法.
背景情况:
- 通过线粒体质量控制 (MQC) 活动进行线粒体超极化是质母细胞瘤 (GBM) 的特征.
- 准MQC来破坏线粒体平衡表现为GBM的潜在治疗策略.
研究的目的:
- 调查MP31微在GBM病变发生中的作用及其作为治疗剂的潜力.
- 阐明MP31影响线粒体平衡和GBM细胞活力的机制.
主要方法:
- 利用2光子和共聚焦光显微镜来评估线粒体膜潜力 (MMP) 和结构.
- 采用光激活细胞分类 (FACS) 和mKeima来量化线粒细胞流量.
- 研究了 lysosomal 功能和 V-ATPase A1/LDHB 相互作用.
主要成果:
- MP31破坏了MQC,诱导了MMP损失,线粒体裂变,并阻断了GBM细胞中的线粒体流.
- MP31 损坏的线粒体的积累,导致反应性氧物种 (ROS) 生产和DNA损伤.
- 在体外和体内,MP31抑制了溶酶体功能,并使GBM细胞对temozolomide (TMZ) 化疗敏感.
结论:
- MP31破坏了GBM线粒体平衡,并增强了对化疗的敏感性.
- MP31证明了对GBM的治疗潜力,对正常的人类星球细胞或微质细胞 (MG) 没有毒性.
相关概念视频
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K